References
Key articles
American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 222: gestational hypertension and preeclampsia. Jun 2020 [internet publication].Full text Abstract
Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022 Mar;27:148-69. Abstract
National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. Apr 2023 [internet publication].Full text
Reference articles
1. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 222: gestational hypertension and preeclampsia. Jun 2020 [internet publication].Full text Abstract
2. Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022 Mar;27:148-69. Abstract
3. Ford ND, Cox S, Ko JY, et al. Hypertensive disorders in pregnancy and mortality at delivery hospitalization - United States, 2017-2019. MMWR Morb Mortal Wkly Rep. 2022 Apr 29;71(17):585-91.Full text Abstract
4. Knight M, Bunch K, Patel R, et al, eds; MBRRACE-UK. Saving lives, improving mothers’ care core report - lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2018-20. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2022.Full text
5. National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. Apr 2023 [internet publication].Full text
6. Innes KE, Wimsatt JH, McDuffie R. Relative glucose tolerance and subsequent development of hypertension in pregnancy. Obstet Gynecol. 2001 Jun;97(6):905-10. Abstract
7. Vidaeff AC, Carroll MA, Ramin SM. Acute hypertensive emergencies in pregnancies. Crit Care Med. 2005 Oct;33(suppl 10):S307-12. Abstract
8. Wolf M, Sandler L, Jimenez-Kimble R, et al. Insulin resistance but not inflammation is associated with gestational hypertension. Hypertension. 2002 Dec;40(6):886-91.Full text Abstract
9. American College of Obstetricians and Gynecologists. Obstetric care consensus no. 11: pregnancy at age 35 years or older. Aug 2022 [internet publication].Full text
10. Lombardi DG, Barton JR, O'Brien JM, et al. Does an obese prepregnancy body mass index influence outcome in pregnancies complicated by mild gestational hypertension remote from term? Am J Obstet Gynecol. 2005 May;192(5):1472-4. Abstract
11. Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol. 1997 Nov;177(5):1003-10. Abstract
12. Michlin R, Oettinger M, Odeh M, et al. Maternal obesity and pregnancy outcome. Isr Med Assoc J. 2000 Jan;2(1):10-3.Full text Abstract
13. Sibai BM, Gordon T, Thom E, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 1995 Feb;172(2 Pt 1):642-8. Abstract
14. Rasmussen S, Irgens LM. Pregnancy-induced hypertension in women who were born small. Hypertension. 2007 Apr;49(4):806-12.Full text Abstract
15. Bismuth E, Bouche C, Caliman C, et al. Management of pregnancy in women with type 1 diabetes mellitus: guidelines of the French-Speaking Diabetes Society (Société francophone du diabète [SFD]). Diabetes Metab. 2012 Jun;38(3):205-16. Abstract
16. Facchinetti F, Allais G, Nappi RE, et al. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia. 2009 Mar;29(3):286-92. Abstract
17. American College of Obstetricians and Gynecologists. Clinical practice guideline no. 3: headaches in pregnancy and postpartum. May 2022 [internet publication].Full text
18. Hofmeyr GJ, Lawrie TA, Atallah ÁN, et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2018 Oct 1;(10):CD001059.Full text Abstract
19. World Health Organization. WHO recommendation on calcium supplementation before pregnancy for the prevention of pre-eclampsia and its complications. Apr 2020 [internet publication].Full text
20. Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017 Aug 17;377(7):613-22.Full text Abstract
21. Duley L, Meher S, Hunter KE, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019 Oct 30;(10):CD004659.Full text Abstract
22. Henderson JT, Vesco KK, Senger CA, et al. Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021 Sep 28;326(12):1192-206.Full text Abstract
23. World Health Organization. WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia. Dec 2021 [internet publication].Full text
24. US Preventive Services Task Force final recommendation statement. Aspirin use to prevent preeclampsia and related morbidity and mortality: preventive medication. Sep 2021 [internet publication].Full text
25. American College of Obstetricians and Gynecologists. ACOG committee opinion no. 743: low-dose aspirin use during pregnancy. Jul 2018 [internet publication].Full text
26. Ashworth DC, Maule SP, Stewart F, et al. Setting and techniques for monitoring blood pressure during pregnancy. Cochrane Database Syst Rev. 2020 Jul 23;(8):CD012739.Full text Abstract
27. Brown MA, Roberts LM, Mackenzie C, et al. A prospective randomized study of automated versus mercury blood pressure recordings in hypertensive pregnancy (PRAM Study). Hypertens Pregnancy. 2012;31(1):107-19. Abstract
28. National Institute for Health and Care Excellence. PLGF-based testing to help diagnose suspected preterm pre-eclampsia. Jul 2022 [internet publication].Full text
29. Duhig KE, Myers J, Seed PT, et al; PARROT trial group. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet. 2019 May 4;393(10183):1807-18.Full text Abstract
30. National Institute for Health and Care Excellence. Antenatal care. Aug 2021 [internet publication].Full text
31. US Preventive Services Task Force. Hypertensive disorders of pregnancy: screening. Sep 2023 [internet publication].Full text
32. National Institute for Health and Care Excellence. Intrapartum care for women with existing medical conditions or obstetric complications and their babies. Apr 2019 [internet publication].Full text
33. Magee LA, Smith GN, Bloch C, et al. Guideline no. 426. Hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management. J Obstet Gynaecol Can. 2022 May;44(5):547-71.e1. Abstract
34. Society of Obstetric Medicine of Australia and New Zealand. Hypertension in pregnancy guideline. Feb 2024 [internet publication].Full text
35. Te Whatu Ora / Health New Zealand. Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy in Aotearoa New Zealand. Oct 2022 [internet publication].Full text
36. Broekhuijsen K, van Baaren GJ, van Pampus MG, et al; HYPITAT-II study group. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet. 2015 Jun 20;385(9986):2492-501. Abstract
37. Cluver C, Novikova N, Koopmans CM, et al. Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term. Cochrane Database Syst Rev. 2017 Jan 15;(1):CD009273.Full text Abstract
38. National Institute for Health and Care Excellence. Preterm labour and birth. Jun 2022 [internet publication].Full text
39. American College of Obstetricians and Gynecologists. Committee opinion no. 455. Magnesium sulfate before anticipated preterm birth for neuroprotection. Mar 2010 (reaffirmed 2023) [internet publication].Full text
40. American College of Obstetricians and Gynecologists. ACOG committee opinion no. 713. Antenatal corticosteroid therapy for fetal maturation. Aug 2017 [internet publication].Full text
41. Gilbert GE, Wahlquist AH, eds. InfoPOEMs: induction of labor may be beneficial at 36 weeks with hypertension. J Natl Med Assoc. 2010 Feb;102(2):151-2.
42. Dowswell T, Middleton P, Weeks A. Antenatal day care units versus hospital admission for women with complicated pregnancy. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD001803.Full text Abstract
43. Kiel DW, Dodson EA, Artal R, et al. Gestational weight gain and pregnancy outcomes in obese women: how much is enough? Obstet Gynecol. 2007 Oct;110(4):752-8. Abstract
44. Tita AT, Szychowski JM, Boggess K, et al; Chronic Hypertension and Pregnancy (CHAP) Trial Consortium. Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022 May 12;386(19):1781-92.Full text Abstract
45. American College of Obstetricians and Gynecologists Practice Advisory. Clinical guidance for the integration of the findings of the Chronic Hypertension and Pregnancy (CHAP) Study. Apr 2022 [internet publication].Full text
46. Abalos E, Duley L, Steyn DW, et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018 Oct 1;(10):CD002252.Full text Abstract
47. Tuffnell DJ, Jankowicz D, Lindow SW, et al; Yorkshire Obstetric Critical Care Group. Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. BJOG. 2005 Jul;112(7):875-80. Abstract
48. Shekhar S, Gupta N, Kirubakaran R, et al. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis. BJOG. 2016 Jan;123(1):40-7. Abstract
49. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 203. Chronic hypertension in pregnancy. Obstet Gynecol. 2019 Jan;133(1):e26-50. Abstract
50. Medicines and Healthcare products Regulatory Agency. Magnesium sulfate: risk of skeletal adverse effects in the neonate following prolonged or repeated use in pregnancy. May 2019 [internet publication].Full text
51. US Food and Drug Administration. FDA drug safety communication: FDA recommends against prolonged use of magnesium sulfate to stop preterm labor due to bone changes in exposed babies. May 2013 [internet publication].Full text
52. Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017 Mar;40(3):213-20. Abstract
53. Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med. 2009 Oct;122(10):890-5. Abstract
54. Fishel Bartal M, Lindheimer MD, Sibai BM. Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance. Am J Obstet Gynecol. 2022 Feb;226(2s):S819-34.Full text Abstract
55. Benschop L, Duvekot JJ, Roeters van Lennep JE. Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. Heart. 2019 Aug;105(16):1273-8.Full text Abstract
56. Wenger NK, Lloyd-Jones DM, Elkind MSV, et al; American Heart Association. Call to action for cardiovascular disease in women: epidemiology, awareness, access, and delivery of equitable health care: a presidential advisory from the American Heart Association. Circulation. 2022 Jun 7;145(23):e1059-71.Full text Abstract
57. Haug EB, Horn J, Markovitz AR, et al. Life course trajectories of cardiovascular risk factors in women with and without hypertensive disorders in first pregnancy: the HUNT study in Norway. J Am Heart Assoc. 2018 Aug 7;7(15):e009250.Full text Abstract
58. Stuart JJ, Tanz LJ, Cook NR, et al. Hypertensive disorders of pregnancy and 10-year cardiovascular risk prediction. J Am Coll Cardiol. 2018 Sep 11;72(11):1252-63.Full text Abstract
59. O'Kelly AC, Michos ED, Shufelt CL, et al. Pregnancy and reproductive risk factors for cardiovascular disease in women. Circ Res. 2022 Feb 18;130(4):652-72.Full text Abstract
60. Paridisi G, Biaggi A, Savone R, et al. Cardiovascular risk factors in healthy women with previous gestational hypertension. J Clin Endocrinol Metab. 2006 Apr;91(4):1233-8.Full text Abstract
61. Forrester KJ, Barton JR, O'Brien JM, et al. The effect of gestational hypertension and gestational diabetes on neonatal outcome. Paper presented at: ACOG 54th annual clinical meeting. 6-10 May 2006. Washington, D.C. Obstet Gynecol. 2006;107(suppl 4):26S.
62. Agrawal A, Wenger NK. Hypertension during pregnancy. Curr Hypertens Rep. 2020 Aug 27;22(9):64. Abstract
63. Karjalainen L, Tikkanen M, Rantanen K, et al. Stroke in pregnancy and puerperium: validated incidence trends with risk factor analysis in Finland 1987-2016. Neurology. 2021 May 25;96(21):e2564-75. Abstract
64. Kremer C, Gdovinova Z, Bejot Y, et al. European Stroke Organisation guidelines on stroke in women: Management of menopause, pregnancy and postpartum. Eur Stroke J. 2022 Jun;7(2):I-XIX.Full text Abstract
65. Sep S, Smits L, Prins M, et al. Prediction tests for recurrent hypertensive disease in pregnancy, a systematic review. Hypertens Pregnancy. 2010 Jan;29(2):206-30. Abstract
66. Tucker KL, Mort S, Yu LM, et al; BUMP Investigators. Effect of self-monitoring of blood pressure on diagnosis of hypertension during higher-risk pregnancy: the BUMP 1 randomized clinical trial. JAMA. 2022 May 3;327(17):1656-65.Full text Abstract
67. Chappell LC, Tucker KL, Galal U, et al; BUMP 2 Investigators. Effect of self-monitoring of blood pressure on blood pressure control in pregnant individuals with chronic or gestational hypertension: the BUMP 2 randomized clinical trial. JAMA. 2022 May 3;327(17):1666-78.Full text Abstract
68. World Health Organization. WHO guideline on self-care interventions for health and well-being, 2022 revision. Jun 2022 [internet publication].Full text
69. Tucker KL, Taylor KS, Crawford C, et al. Blood pressure self-monitoring in pregnancy: examining feasibility in a prospective cohort study. BMC Pregnancy Childbirth. 2017 Dec 28;17(1):442.Full text Abstract
70. Tucker KL, Bowen L, Crawford C, et al. The feasibility and acceptability of self-testing for proteinuria during pregnancy: a mixed methods approach. Pregnancy Hypertens. 2018 Apr;12:161-8.Full text Abstract
Use of this content is subject to our disclaimer